Back
Karyopharm Therapeutics Stock Price Chart

5 Stocks to Consider Immediately (must-see chart)
See the green days for 5 major stocks right here, free of charge
Sell
31
KPTI
Karyopharm Therapeutics
Last Price:
$4.49
Seasonality Move:
-6.23%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
The current trend is relatively stagnant and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.
Karyopharm Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.46 | Sell |
20-day SMA: | 4.41 | Sell |
50-day SMA: | 5.05 | Sell |
200-day SMA: | 8.62 | Sell |
8-day EMA: | 4.44 | Sell |
20-day EMA: | 4.48 | Sell |
50-day EMA: | 4.9 | Sell |
200-day EMA: | 8.32 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 45.77 | Sell |
Chaikin Money Flow: | -36017 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.27 - 4.51) | Sell |
Bollinger Bands (100): | (4.06 - 7.38) | Sell |
Karyopharm Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 4.39 while KPTI 8-day simple moving average is 4.46, which is a Sell signal.
-
The stock price of KPTI is 4.39 while Karyopharm Therapeutics 20-day SMA is 4.41, which makes it a Sell.
-
Karyopharm Therapeutics 50-day simple moving average is 5.05 while KPTI share price is 4.39, making it a Sell technically.
-
KPTI stock price is 4.39 and Karyopharm Therapeutics 200-day simple moving average is 8.62, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
31
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a SellThe current Karyopharm Therapeutics [KPTI] share price is $4.39. The Score for KPTI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
37.9M
Price in USD:
4.39
Share Volume:
36K
Karyopharm Therapeutics 52-Week Range
52-Week High:
16.95
52-Week Low:
3.51
Sell
31
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?The Karyopharm Therapeutics stock price is 4.39 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 4.39 while KPTI 8-day exponential moving average is 4.44, which is a Sell signal.
-
The stock price of KPTI is 4.39 while Karyopharm Therapeutics 20-day EMA is 4.48, which makes it a Sell.
-
Karyopharm Therapeutics 50-day exponential moving average is 4.90 while KPTI share price is 4.39, making it a Sell technically.
-
KPTI stock price is 4.39 and Karyopharm Therapeutics 200-day simple moving average is 8.32, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $2.02 per share, an increase this year of $0.39 per share, and an increase next year of $5.80 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Karyopharm Therapeutics is a Sell
-
Karyopharm Therapeutics Relative Strength Index (RSI) is 45.77, which suggest Karyopharm Therapeutics is oversold
-
The Bollinger Bands (25) for Karyopharm Therapeutics is (4.27 - 4.51), which suggest Karyopharm Therapeutics is a Sell
-
The Bollinger Bands (100) for Karyopharm Therapeutics is (4.06 - 7.38), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.